N Parker
Taken from ki4u.com.....10 000 microsieverts = 1 rem (R)...so if we have 3200 uSeiverts, your looking at .32 R an hour absorption. Not bad at all when at "wartime", but bad for those being exposed to it everyday....
TOTAL EXPOSURE ONSET & DURATION OF INITIAL SYMPTOMS & DISPOSITION
30 to 70 R From 6-12 hours: none to slight incidence of transient headache and nausea;
vomiting in up to 5 percent of personnel in upper part of dose range. Mild
lymphocyte depression within 24 hours. Full recovery expected. (Fetus damage
possible from 50R and above.)
70 to 150 R From 2-20 hours: transient mild nausea and vomiting in 5 to 30 percent of
personnel. Potential for delayed traumatic and surgical wound healing,
minimal clinical effect. Moderate drop in lymphocycte, platelet, and
granulocyte counts. Increased susceptibility to opportunistic pathogens.
Full recovery expected.
150 to 300 R From 2 hours to three days: transient to moderate nausea and vomiting in
20 to 70 percent; mild to moderate fatigability and weakness in 25 to 60
percent of personnel. At 3 to 5 weeks: medical care required for 10 to 50%.
At high end of range, death may occur to maximum 10%. Anticipated medical
problems include infection, bleeding, and fever. Wounding or burns will
geometrically increase morbidity and mortality.
300 to 530 R From 2 hours to three days: transient to moderate nausea and vomiting in 50
to 90 percent; mild to moderate fatigability in 50 to 90 percent of personnel.
At 2 to 5 weeks: medical care required for 10 to 80%. At low end of range,
less than 10% deaths; at high end, death may occur for more than 50%.
Anticipated medical problems include frequent diarrheal stools, anorexia,
increased fluid loss, ulceration. Increased infection susceptibility during
immunocompromised time-frame. Moderate to severe loss of lymphocytes.
Hair loss after 14 days.
530 to 830 R From 2 hours to two days: moderate to severe nausea and vomiting in 80 to
100 percent of personnel; From 2 hours to six weeks: moderate to severe
fatigability and weakness in 90 to 100 percent of personnel. At 10 days to
5 weeks: medical care required for 50 to 100%. At low end of range, death
may occur for more than 50% at six weeks. At high end, death may occur
for 99% of personnel. Anticipated medical problems include developing
pathogenic and opportunistic infections, bleeding, fever, loss of appetite,
GI ulcerations, bloody diarrhea, severe fluid and electrolyte shifts, capillary
leak, hypotension. Combined with any significant physical trauma, survival
rates will approach zero.
830 R Plus From 30 minutes to 2 days: severe nausea, vomiting, fatigability, weakness,
dizziness, and disorientation; moderate to severe fluid imbalance and headache.
Bone marrow total depletion within days. CNS symptoms are predominant at
higher radiation levels. Few, if any, survivors even with aggressive and
immediate medical attention.
TOTAL EXPOSURE ONSET & DURATION OF INITIAL SYMPTOMS & DISPOSITION
30 to 70 R From 6-12 hours: none to slight incidence of transient headache and nausea;
vomiting in up to 5 percent of personnel in upper part of dose range. Mild
lymphocyte depression within 24 hours. Full recovery expected. (Fetus damage
possible from 50R and above.)
70 to 150 R From 2-20 hours: transient mild nausea and vomiting in 5 to 30 percent of
personnel. Potential for delayed traumatic and surgical wound healing,
minimal clinical effect. Moderate drop in lymphocycte, platelet, and
granulocyte counts. Increased susceptibility to opportunistic pathogens.
Full recovery expected.
150 to 300 R From 2 hours to three days: transient to moderate nausea and vomiting in
20 to 70 percent; mild to moderate fatigability and weakness in 25 to 60
percent of personnel. At 3 to 5 weeks: medical care required for 10 to 50%.
At high end of range, death may occur to maximum 10%. Anticipated medical
problems include infection, bleeding, and fever. Wounding or burns will
geometrically increase morbidity and mortality.
300 to 530 R From 2 hours to three days: transient to moderate nausea and vomiting in 50
to 90 percent; mild to moderate fatigability in 50 to 90 percent of personnel.
At 2 to 5 weeks: medical care required for 10 to 80%. At low end of range,
less than 10% deaths; at high end, death may occur for more than 50%.
Anticipated medical problems include frequent diarrheal stools, anorexia,
increased fluid loss, ulceration. Increased infection susceptibility during
immunocompromised time-frame. Moderate to severe loss of lymphocytes.
Hair loss after 14 days.
530 to 830 R From 2 hours to two days: moderate to severe nausea and vomiting in 80 to
100 percent of personnel; From 2 hours to six weeks: moderate to severe
fatigability and weakness in 90 to 100 percent of personnel. At 10 days to
5 weeks: medical care required for 50 to 100%. At low end of range, death
may occur for more than 50% at six weeks. At high end, death may occur
for 99% of personnel. Anticipated medical problems include developing
pathogenic and opportunistic infections, bleeding, fever, loss of appetite,
GI ulcerations, bloody diarrhea, severe fluid and electrolyte shifts, capillary
leak, hypotension. Combined with any significant physical trauma, survival
rates will approach zero.
830 R Plus From 30 minutes to 2 days: severe nausea, vomiting, fatigability, weakness,
dizziness, and disorientation; moderate to severe fluid imbalance and headache.
Bone marrow total depletion within days. CNS symptoms are predominant at
higher radiation levels. Few, if any, survivors even with aggressive and
immediate medical attention.